-
FDA use of Real-World Evidence in Regulatory Decision Making
23 Sep 2025 03:56 GMT
… Allergy Drug Montelukast (Singulair); Advises Restricting Use for Allergic Rhinitis
… to years, a medication guide, required manufacturers to … clinical trial used to approve Pradaxa. FDA issued … of developing severe COVID-19. An FDA conducted …
-
Efficacy and Safety of Omalizumab Combined with Allergen-Specific Immunotherapy in the Treatment of Moderate-to-Severe Allergic Asthma: A Prospective Cohort Study in a Chinese Population
22 Sep 2025 13:15 GMT
… . These limitations frequently lead to treatment discontinuation and poor adherence, reducing … to AIT alone, previous randomized trials and meta-analyses consistently compared … , Cingi C. Biologics in allergic rhinitis. Eur Rev Med Pharmacol Sci. 2023;27 …
-
Inhibition of LOXL2 Suppresses Nasal Mucosal Inflammation and Remodeling in Allergic Rhinitis
15 Sep 2025 07:08 GMT
… approach opens new avenues for developing targeted therapeutic strategies for AR … Nasal Epithelial Cell Culture and Treatment
Fresh inferior turbinate specimens were … EJ, Overholser A, Schultz P. Allergic rhinitis. Med Clin North Am. 2024;108 …
-
Polyrizon Submits Pre-Sub Package to the FDA for PL-14 Allergy Blocker
19 Sep 2025 12:15 GMT
… S. Food and Drug Administration (FDA) for its PL … long-lasting relief from allergic rhinitis symptoms by blocking allergen … treatment options. This submission positions Polyrizon for accelerated development … for intranasal delivery of drugs. Polyrizon refers to …
-
Targeted Degradation of Keap1: A Novel PROTAC Approach for Treating Allergic Rhinitis
08 Sep 2025 21:43 GMT
… innovative and potentially revolutionary treatment approach for allergic rhinitis (AR), a … patients.
In preclinical trials conducted in an allergic rhinitis mouse model, … foundational biological processes in developing effective treatments. As this research …
-
Aptar Pharma & Dianosic partner to advance the ARIS platform to treat chronic allergic rhinitis and chronic rhinosinusitis
08 Sep 2025 09:40 GMT
… therapeutic solutions, for the development of an Active Resorbable Intranasal … delivering drugs locally over extended periods for the treatment of chronic allergic rhinitis (CAR … leveraging the potential of intranasal drug-delivery,” said Alex Theodorakis, …
-
A Bibliometric Analysis of Chinese Medicine for Allergic Rhinitis
06 Sep 2025 11:01 GMT
… these drugs require long treatment cycles … analysis software developed by Prof. … Treatment for seasonal allergic rhinitis by Chinese herbal medicine: a randomized placebo controlled trial … persistent allergic rhinitis: a randomised, sham-controlled trial. Med …
-
An Indian Cross-Sectional Study to Evaluate In-Clinic Allergic Rhinitis Prevalence in Patients Having Nasal Symptoms Using the SFAR Questionnaire
03 Sep 2025 20:34 GMT
… ) conducted in Poland on the development of a plausible tool for … to treatment guidelines (India: 44%, China: 40%) and incorrect use of medication … and its seasonal variation in allergic rhinitis. J Med Sci. 2019;5(3 …
-
Harnessing Nature’s Remedy: Local Raw Honey as Immunotherapy for Allergic Rhinitis and Seasonal Allergies
26 Aug 2025 21:52 GMT
… trials are needed to definitively establish honey’s effectiveness for allergy treatment … of anticholinergic medications, including many … drugs, and antiparkinsonian drugs as … Development Group. AAO-HNSF. Clinical practice guideline: Allergic rhinitis …
-
Real-World Korean Registry for Allergic Rhinitis
23 Aug 2025 15:16 GMT
… the management and treatment strategies for allergic rhinitis remain suboptimally … Unlike traditional clinical trials that often operate … foster innovation in developing new treatment strategies and … registry protocol.
BMC Complement Med Ther 25, 282 …
About
© 1995-2025